Construction and Comprehensive Analysis of Dysregulated Long Noncoding RNA-Associated Competing Endogenous RNA Network in Moyamoya Disease

Table 2

List of the top 10 potential small molecular drugs predicted by CMap. Scores indicate the strong negative correlation found between MMD and drugs.

	Score	Type	ID	Name	Description
1	-88.5	cp	BRD-K86727142	Embelin	HCV inhibitor
2	-88.74	cp	BRD-K11630072	Carmofur	Thymidylate synthase inhibitor
3	-90.86	cp	BRD-A61858259	CAY-10415	Insulin sensitizer
4	-91.54	cp	BRD-K04923131	GSK-3-inhibitor-IX	Glycogen synthase kinase inhibitor
5	-91.85	cp	BRD-K53959060	Indirubin	CDK inhibitor
6	-93.79	cp	BRD-K50720187	Flupirtine	Glutamate receptor antagonist
7	-93.87	cp	BRD-A14985772	Ascorbyl-palmitate	Antioxidant
8	-94.57	cp	BRD-K28143534	Cyproheptadine	Histamine receptor antagonist
9	-95.78	cp	BRD-K79404599	Enzastaurin	PKC inhibitor
10	-97.25	cp	BRD-K89687904	PKCbeta-inhibitor	PKC inhibitor